Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.


Treatment with single-agent chemotherapy or rituximab (R) is safe and moderately effective for patients with Waldenström macroglobulinemia (WM). We analyzed the efficacy and toxicity of fludarabine (F)-combinations. Twenty-nine treatment episodes were administered to 27 patients, including FC (F 25 mg/m(2) days 1-3, cyclophosphamide [C] 250 mg/m(2) days 1-3… (More)
DOI: 10.3109/10428194.2010.524326


6 Figures and Tables